|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/437 | |||
| A61P 25/28 |
| (11) | Number of the document | 3532476 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17794522.7 |
| Date of filing the European patent application | 2017-10-20 | |
| (97) | Date of publication of the European application | 2019-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057564 |
| Date | 2017-10-20 |
| (87) | Number | WO 2018/080916 |
| Date | 2018-05-03 |
| (30) | Number | Date | Country code |
| 201662412867 P | 2016-10-26 | US |
| (72) |
AMERIKS, Michael K., US
LAFORTEZA, Brian Ngo, US
LEBOLD, Terry Patrick, US
RAVULA, Suchitra, US
SAVALL, Brad M., US
SHIREMAN, Brock T., US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | FUSED AZAHETEROCYCLIC COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| FUSED AZAHETEROCYCLIC COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |